Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
63.80+1.15 (+1.84%)
At close: 04:00PM EDT
61.88 -1.92 (-3.01%)
After hours: 04:05PM EDT
Advertisement
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
No. of Analysts16161717
Avg. Estimate-1.74-1.71-7.21-5.77
Low Estimate-2.31-2.31-8.9-8.32
High Estimate-1.23-1.21-5.42-3.43
Year Ago EPS-1.81-1.08-6.7-7.21
Revenue EstimateCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
No. of Analysts13131617
Avg. Estimate88.09M95.6M373.33M479.89M
Low Estimate80.9M81.6M349.8M302.8M
High Estimate99.8M110M433M758.98M
Year Ago Sales86.97M81.65M351.41M373.33M
Sales Growth (year/est)1.30%17.10%6.20%28.50%
Earnings History6/29/20219/29/202112/30/20213/30/2022
EPS Est.-1.33-1.41-1.34-1.76
EPS Actual-1.81-1.08-1.79-2.19
Difference-0.480.33-0.45-0.43
Surprise %-36.10%23.40%-33.60%-24.40%
EPS TrendCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
Current Estimate-1.74-1.71-7.21-5.77
7 Days Ago-1.74-1.71-7.21-5.77
30 Days Ago-1.74-1.71-7.2-5.62
60 Days Ago-1.56-1.7-6.55-4.77
90 Days Ago-1.55-1.69-6.47-4.79
EPS RevisionsCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRAREIndustrySector(s)S&P 500
Current Qtr.3.90%N/AN/AN/A
Next Qtr.-58.30%N/AN/AN/A
Current Year-7.60%N/AN/AN/A
Next Year20.00%N/AN/AN/A
Next 5 Years (per annum)-87.60%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A
Advertisement
Advertisement